Yale Law School Center for the Study of Corporate Law

Victoria Cundiff’s Intellectual Property: Working with Patents and Trade Secrets Course Fall 2023 Schedule

Fall 2023 Intellectual Property Course Schedule

  • Open to the Yale community only.
  • All course guest lectures will take place from 2:10 to 4:00 p.m.  If you are interested in attending a lecture, please email Victoria Cundiff (victoria.cundiff@yale.edu), Visiting Lecturer in Law, before the lecture takes place.
  • Guest lecturers with an asterisk (*) in their entries will also be available for lunch beforehand, from 12:10 to 1:00 p.m., as part of the inaugural Nathan Lunch Series on Intellectual Property. For more information on the Nathan Lunch Series, please contact Nancy Liao (nancy.liao@yale.edu).

​

Date   Speaker
Thursday, Sept. 21*  

John F. Duffy, Samuel H. McCoy II Professor of Law and Paul G. Mahoney Research Professor of Law, University of Virginia Law School, “Patent Subject Matter Eligibility: A Friendly Proposal”
Thursday, Sept. 28  

Hon. Richard G. Taranto, YLS ’81, United States Court of Appeals for the Federal Circuit, “Working With IP: A View From the Bench”
Thursday, Oct. 5*  

Richard L. Thurston, former Senior Vice President and General Counsel, Taiwan Semiconductor Manufacturing Company, Ltd., “Recognizing Strategic Value from Trade Secrets”
Thursday, Oct. 12

Neel Chatterjee, Partner, Goodwin Proctor LLP, Silicon Valley, “Data as an Asset”
Thursday, Oct. 19*  

Robert Greene Sterne, Founder and Director, Sterne Kessler, Washington, D.C., “Instituting Institutions: the PTAB and the Unified Patent Court”
Thursday, Oct. 26*

Ryan Abbott, YLS ’11, Lawyer, Physician, Mediator, and Professor, University of Surrey School of Law and UCLA David Geffen School of Medicine, “Artificial Intelligence: Is Everything ‘Obvious’?”
Thursday, Nov. 9*  

A. John P. Mancini, Partner, Mayer Brown LLP, Global Intellectual Property Practice, and Jon Putnam, Ph.D., Founder, Competition Dynamics, “Litigating Trade Secret Liability and Remedies”
Thursday, Nov. 16*  

Katherine A. High, M.D.; Co-Founder, President and Chief Scientific Officer Emerita, Spark Therapeutics; Professor of Pediatrics and Medicine Emerita, Perelman School of Medicine, University of Pennsylvania; and Visiting Professor, Rockefeller University, “From Concept to Commercialization: Thirty Years of Problem Solving”